Asian Stock: Santen Pharmaceutical

By Andrew Stotz of Become A Better Investor
Tuesday, October 15, 2024 8:48 AM EDT

Company: Santen Pharmaceutical Company Limited

Bloomberg ticker: 4536 JP

Market cap: US$4,532m

Background: Santen Pharmaceutical Company Limited is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
 

World Class Benchmarking of Santen Pharmaceutical

(Click on image to enlarge)

  • Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to 360 large Health Care companies worldwide
  • Profitability rank of 3 was worse than its Growth rank of 1
  • Profitability rank of 3 was the same compared to the prior period’s 3rd rank
  • This is above average performance compared to peers
  • Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to peers

More By This Author:

Asian Stock: Goertek
Australian Stock: AGL Energy
Asian Stock: Pakuwon Jati

Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments